Metorax Tablet

About Metorax 2.5 mg Tablet

Metorax is a tablet from Renata PLC. It contains methotrexate 2.5 mg and is an immunosuppressant. Doctors use it for certain cancers and severe inflammatory conditions. It is a specialist medicine, not for self-use.

There are 4 brands of Methotrexate listed in Bangladesh. The lowest listed price is Methotrax 2.5 mg Tablet at ৳ 5.00 per unit.

What is Metorax 2.5 mg Tablet?

Metorax is a tablet made by Renata PLC. It contains methotrexate 2.5 mg, a medicine that belongs to a group called immunosuppressants. Methotrexate works by affecting how cells grow and divide, which is why it is used in some cancers and in certain long-term inflammatory diseases. It is a strong medicine that only a specialist doctor should prescribe and monitor. The dose and course are always decided by the doctor. Before and during treatment, the doctor may arrange blood tests to check how you are responding. Never start, stop or change this medicine on your own.

Uses of Metorax

Metorax is used in the treatment of certain cancers, including some cancers of the womb and breast, and in the maintenance phase of some leukaemias and lymphomas. It is also prescribed for severe inflammatory conditions such as psoriasis, rheumatoid arthritis and Crohn's disease. Only a specialist doctor can decide whether it is suitable. Ask your doctor what it is being used for in your case.

How to use Metorax

Take Metorax exactly as your doctor tells you. The doctor decides the dose, how often to take it and how long the course lasts. Swallow the tablet with water, with or without food, unless your doctor advises otherwise. Do not take extra tablets or stop early without talking to your doctor. Keep all appointments for blood tests and check-ups, and tell your doctor about any new symptoms. Store at room temperature, away from children.

Side effects of Metorax

Metorax can cause side effects. Common ones include mouth ulcers, stomach upset, diarrhoea, nausea and hair loss. It can also affect the bone marrow, liver and kidneys, so the doctor monitors you with blood tests. Other possible effects are skin reactions, eye irritation, joint pain and fertility problems. Some effects can be serious. Tell your doctor promptly about mouth sores, fever, unusual tiredness, bruising, bleeding or any new symptom.

Safety and precautions

Metorax must not be used in pregnancy or while breast-feeding. It is not for people with severe kidney or liver problems, severe bone marrow suppression, alcoholic liver disease, AIDS or certain blood disorders. Tell your doctor if you have liver or kidney problems, are elderly, or have stomach or bowel ulcers. The doctor will arrange regular blood tests to check your blood, liver and kidneys. Do not take other medicines, including vitamins, without asking your doctor. Ask your doctor first if you have any doubts.

Frequently asked questions

Who should avoid Metorax or ask the doctor first?

Do not take Metorax if you are pregnant or breast-feeding, or if you have severe kidney or liver problems, severe bone marrow suppression, alcoholic liver disease, AIDS or certain blood disorders. Tell your doctor if you are elderly, have ulcers or any long-term illness. Always ask your doctor before starting this medicine.

What is Metorax used for and what kind of medicine is it?

Metorax is an immunosuppressant. It is used for certain cancers, such as some cancers of the womb and breast, and for severe inflammatory conditions including psoriasis, rheumatoid arthritis and Crohn's disease. Only a specialist doctor can decide if it is right for you and what it is being used for.

What does the generic name methotrexate mean?

Methotrexate is the generic name of the active ingredient in Metorax. It belongs to a group of medicines called immunosuppressants. Methotrexate works by interfering with how certain cells grow and divide, which is why it is used in some cancers and severe inflammatory diseases.

Can I take other medicines or vitamins with Metorax?

Do not take any other medicine, vitamin or supplement without asking your doctor first. Some medicines, including folic acid products, can affect how Metorax works. Your doctor needs to check for interactions and may adjust your treatment. Always tell your doctor about everything you are taking.

Indications

Neoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or ... Read moreNeoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast  cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types. Methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-Hodgkin's lymphomas.

Psoriasis: Methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation. It is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affecting immune responses.

Rheumatoid Arthritis Including Polyarticular-Course Juvenile Rheumatoid Arthritis: Methotrexate is indicated in the management of selected adults with severe, active, rheumatoid arthritis (ACR criteria), or children with active polyarticular course juvenile rheumatoid arthritis, who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs).

Aspirin, NSAIDs, and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of NSAIDs including salicylates has not been fully explored. Steroids may be reduced gradually in patients who respond to methotrexate. Combined use of methotrexate with gold, penicillamine, hydroxychloroquine, sulfasalazine, or cytotoxic agents, has not been studied and may increase the incidence of adverse effects. Rest and physiotherapy as indicated should be continued.

Pharmacology

Methotrexate inhibits dihydrofolic acid reductase. Dihydrofolates must be reduced to tetrahydrofolates by this enzyme before they can be utilized as carriers of one-carbon groups in the synthesis of p.r.n. nucleotides and thymidylate. Therefore, methotrexate interferes with DNA synthesis, repair, and cellular replication. Actively proliferating tissues such as malignant cells, bone marrow, fetal cells, buccal and intestinal mucosa, and cells of the urinary bladder are in general more sensitive to this effect of methotrexate. When cellular proliferation in malignant tissues is greater than in most normal tissues, methotrexate may impair malignant growth without irreversible damage to normal tissues

Dosage & Administration

Oral-
  • Choriocarcinoma: 15-30 mg daily for 5 days, repeat after an interval of ≥1 wk for 3-5 courses.
  • Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents.
  • Burkitt's lymphoma: 10-25 mg daily for 4-8 days, repeated after 7-10 days.
  • Psoriasis: 10-25 mg wkly as a single dose, adjust subsequent doses based on response.
  • Rheumatoid arthritis: 7.5 mg once wkly, adjust by response. Not more than 20 mg/wk.
  • Mycosis fungoides: 2.5-10 mg daily to induce remission.
  • Crohn's disease: 12.5-22.5 mg once wkly for up to 1 yr.
Parenteral-
  • Psoriasis: 10-25 mg wkly as a single dose. Adjust subsequent doses based on response. May be given via IV/IM admin.
Intramuscular-
  • Choriocarcinoma: 15-30 mg daily for 5 days. Repeat after at least 1 wk for 3-5 courses. Alternatively, 0.25-1 mg/kg (max: 60 mg) every 48 hr for 4 doses followed by folinic acid rescue, repeat at intervals of 7 days for 4 or more courses.
  • Mycosis fungoides: 50 mg wkly as a single dose or 2 divided doses.
  • Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents.
  • Crohn's disease: 25 mg once wkly for 16 wk. Maintenance: 15 mg wkly.
Intrathecal-
  • Meningeal leukaemia: 12 mg/m2 (max 15 mg) once wkly for 2-3 wk, then once mthly. Alternatively, 200-500 mcg/kg every 2-5 day until CSF cell count is normalised.
Intravenous-
  • Osteosarcoma: Initial recommended dose: 12 g/m2 as a 4-hr infusion, followed by folinic acid, as part of combined therapy. May increase dose to 15 g/m2 in subsequent treatments if initial dosage is insufficient to achieve peak serum methotrexate levels of 454 mcg/mL at the end of the infusion. Methotrexate infusion is administered on postoperative wk 4, 5, 6, 7, 11, 12, 15, 16, 29, 30, 44 and 45; in combination with other chemotherapy agents. Folinic acid can be given orally, IM or IV inj starting 24 hr after the beginning of the methotrexate infusion. Give via parenteral routes If patient experiences GI toxicity (e.g., nausea, vomiting). Usual dosage of folinic acid: 15 mg every 6 hr for a total of 60 hr or a total of 10 doses.
  • Breast cancer: 10-60 mg/m2 often with cyclophosphamide and fluorouracil.
  • Advanced lymphosarcoma: Up to 30 mg/kg, followed by folinic acid rescue.
  • Acute lymphoblastic leukaemia: Maintenance: 2.5 mg/kg every 14 days.

Interaction

Decreased effectiveness with folic acid and its derivatives.

Contraindications

Severe renal or hepatic impairment, pre-existing profound bone marrow suppression in patients with psoriasis or rheumatoid arthritis, alcoholic liver disease, AIDS, pre-existing blood dyscrasias, pregnancy (in patients with psoriasis or rheumatoid arthritis), breast-feeding.

Side Effects

Ulceration of the mouth and GI disturbances (e.g. stomatitis and diarrhoea), bone marrow depression, hepatotoxicity, renal failure, skin reactions, alopecia, ocular irritation, arachnoiditis in intrathecal use, megaloblastic anaemia, osteoporosis, precipitation of diabetes, arthralgias, necrosis of soft tissue and bone, anaphylaxis, impaired fertility.

Pregnancy & Lactation

Pregnancy category X. Studies in animals or human beings have demonstrated fetal abnormalities or there is evidence of fetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.

Precautions & Warnings

Hepatic or renal impairment, bone marrow depression, elderly, neonates. Ulcerative disorders of the GI tract. Monitor haematological, renal and hepatic function, and GI toxicity regularly.

Overdose Effects

Nausea, vomiting, alopecia, melena, and renal failure.

Storage Conditions

Store at room temperature (15-25°C).

Alternative brands of Methotrexate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.